You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.
On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally engaged with GraftAssure technology by end of 2025GraftAssure assay’s head-to ...
YORKTOWN HEIGHTS, New York, Nov. 7, 2025 /PRNewswire/ -- IBM (NYSE: IBM) today announced it has been selected for Stage B, the second of three stages of the Quantum Benchmarking Initiative led by ...
Future expense trends -- Both SG&A and R&D are anticipated to rise starting in Q4 2025 as the company invests in commercial ...
After-tax NPV8 of US$1.1B based on Mineral Reserves TORONTO, ON / ACCESS Newswire / November 6, 2025 / Aclara Resources Inc. ("Aclara" or the "Company") is pleased to announce the filing and results ...
"We believe transparency is a core requirement for any project entering the next phase of DeFi adoption,” said an XRP Tundra spokesperson. "With several presale milestones approaching in 2025, this is ...
The QA/QC validation process undertaken for the 2025 updated mineral resource and reserve estimates for the Xavantina Operations is consistent with the process set out in the 2022 Xavantina Technical ...
Federal Funding Delays -- CFO David K. Traverse and CEO Ajay Amlani indicated appropriations and revenues from U.S.
Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology compan ...
Good afternoon, and welcome to Aware's Third Quarter 2025 Conference Call. Joining us today are the company's CEO and President, Ajay Amlani; CFO, David Traverse; and CRO, Brian Krause. [Operator ...
Coeur Mining, Inc. ("Coeur" or the "Company") (NYSE: CDE) today reported record third quarter 2025 financial results, including revenue of $555 million and cash flow from operating activities of $238 ...
Detailed price information for Nautilus Biotechnology Inc (NAUT-Q) from The Globe and Mail including charting and trades.